BI
ABBV icon

Berkeley Inc’s AbbVie ABBV Stock Holding History

Berkeley Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,501
Closed -$1.01M – 79
2022
Q3 		$1.01M Buy
7,501
+45
+0.6% +$6.46K 0.85% 31
2022
Q2 		$1.14M Sell
7,456
-174
-2% -$26.6K 0.91% 30
2022
Q1 		$1.24M Sell
7,630
-17,158
-69% -$2.49M 0.86% 35
2021
Q4 		$3.36M Buy
24,788
+269
+1% +$31.8K 2.23% 13
2021
Q3 		$2.64M Sell
24,519
-210
-0.8% -$24K 1.95% 18
2021
Q2 		$2.79M Buy
24,729
+471
+2% +$53K 2% 17
2021
Q1 		$2.63M Buy
24,258
+4,364
+22% +$467K 1.95% 17
2020
Q4 		$2.13M Buy
+19,894
New +$1.91M 1.72% 19

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkeley Inc's ABBV Position: Q4 2022 in Review

Berkeley Inc sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 7,501 shares — an estimated $1.01M sold.

Berkeley Inc first reported a position in ABBV in Q4 2020 and held it in 8 quarters. The position peaked at $3.36M in Q4 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Berkeley Inc reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Berkeley Inc sold 7,501 AbbVie shares in Q4 2022, an estimated $1.01M.
  • Berkeley Inc first reported a position in AbbVie in Q4 2020 and held it in 8 quarters.
  • Berkeley Inc's AbbVie position peaked at $3.36M in Q4 2021.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Berkeley Inc's 13F filing for Q4 2022, filed 4 Mar 2025.